Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
MEDICAL FRONTIERS - American Transplant Congress
Simplifying Immunosuppression Regimens Post-Transplantation
Philadelphia, Pennsylvania / April 30-May 4, 2011
Incremental Gains in Renal Transplantation Organ transplantation, made possible by effective strategies to prevent rejection, has been one of the major success stories in medicine over the past several decades. Due to incremental...
PRIORITY PRESS - World Congress of Nephrology 2011
Advances in the Understanding of the Pathology and Treatment of Chronic Kidney Disease and Associated Cardiovascular Disease
Vancouver, British Columbia / April 8-12, 2011
Vancouver - It is now well established that there is a close association between advancing chronic kidney disease (CKD) and cardiovascular disease (CVD). However, the characteristics of CVD seen in patients with CKD differ substantially...
PRIORITY PRESS - 43rd Annual Meeting and Scientific Exhibition of the American Society of Nephrology (ASN)
Reducing Cardiovascular Risk in Chronic Kidney Disease
Denver, Colorado / November 16-21, 2010
Denver - For the first time, lipid-lowering therapy has demonstrated the potential to reduce cardiovascular (CV) risk in patients with chronic kidney disease. Treatment with a fixed-dose combination therapy, ezetimibe 10 mg/simvastatin 20...
PRIORITY PRESS - 43rd Annual Meeting and Scientific Exhibition of the American Society of Nephrology – Renal Week 2010
Exploring New Treatment Options for Atypical Hemolytic Uremic Syndrome
Denver, Colorado / November 16-21, 2010
Denver - Atypical hemolytic uremic syndrome (aHUS) is a rare chronic disease caused by uncontrolled complement activation where affected patients develop systemic thrombotic microangiopathy and severe thrombocytopenia that tends to centre...
MEDICAL FRONTIERS - 2010 Congress of the European Renal Association and European Dialysis and Transplant Association (ERA-EDTA)
Controlling Hyperphosphatemia in Patients with Chronic Kidney Disease
Munich, Germany / June 25-28, 2010
Munich - Even between non-calcium-containing agents, phosphate binders used in dialysis patients appear to differ substantially. While these differences are now being closely evaluated for their influence on outcome, the attention generated...
JOURNAL CLUB - Transplantation
Immunosuppression for Kidney Transplant Recipients: Evidence-based KDIGO Practice Guidelines
June 2010
Based on The KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients. Am J Transplant 2009;9(suppl 3):S1-S155. IMMUNOSUPPRESSION FOR KIDNEY TRANSPLANT RECIPIENTS: EVIDENCE-BASED KDIGO PRACTICE GUIDELINES Editorial...
PRIORITY PRESS - American Transplant Congress 2010
Improving Long-term Outcomes in Kidney Transplant Recipients
San Diego, California / May 1-5, 2010
San Diego - The calcineurin inhibitors (CNIs) have long been the anchor of transplant immunosuppression, leading to low acute rejection rates in the short term. However, short-term gains have had little impact on long-term graft survival,...
PRIORITY PRESS - American Transplant Congress 2009
Preserving Organ Function with Non-CNI-Based Immunosuppressive Regimens
Boston, Massachusetts / May 30-June 3, 2009
Boston - Recognizing that calcineurin inhibitors (CNIs) may be nephrotoxic and/or diabetogenic, immunosuppressive protocols that minimize exposure to CNIs have gained acceptance in a variety of transplantation settings. Studies discussed...
PRIORITY PRESS - American Transplant Congress 2009
Outcomes in Kidney Transplant Recipients: Focus on Diabetes and BK-associated Nephropathy
Boston, Massachusetts / May 30-June 3, 2009
Boston - Short-term equivalency has been demonstrated for calcineurin inhibitors (CNIs) in widespread use today for prevention or treatment of graft rejection. Differences begin to emerge as outcomes are assessed over the longer term,...